(2S,3S,4S,5R,6S)-6-(4-((2S,3R)-1-(4-Fluorophenyl)-3-((S)-3-(4-Fluorophenyl)-3-Hydroxypropyl)-4-Oxoazetidin-2-Yl)Phenoxy)-3,4,5-Trihydroxytetrahydro-2H-Pyran-2-Carboxylic Acid (2S,3S,4S,5R,6S)-6-(4-((2S,3R)-1-(4-氟苯基)-3-((S)-3-(4-氟苯)-3-羟丙基)-4-氧代氮杂环丁烷-2-基)苯氧基)-3,4,5-三羟基四氢-2H-吡喃-2-羧酸

CAS 190448-57-8 MFCD08063721

化学结构图

190448-57-8
SMILES:

化学属性

Mol. FormulaC30H29F2NO9
Mol. Weight585.553

别名和识别编码

Chemical Name(2S,3S,4S,5R,6S)-6-(4-((2S,3R)-1-(4-Fluorophenyl)-3-((S)-3-(4-Fluorophenyl)-3-Hydroxypropyl)-4-Oxoazetidin-2-Yl)Phenoxy)-3,4,5-Trihydroxytetrahydro-2H-Pyran-2-Carboxylic Acid
Chemical Name Translation(2S,3S,4S,5R,6S)-6-(4-((2S,3R)-1-(4-氟苯基)-3-((S)-3-(4-氟苯)-3-羟丙基)-4-氧代氮杂环丁烷-2-基)苯氧基)-3,4,5-三羟基四氢-2H-吡喃-2-羧酸
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Lee DH, et al. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Free Radic Biol Med. 2016 Sep 12;99:520-532.
  • [1]. Stolk MF, et al. Severe hepatic side effects of ezetimibe. Clin Gastroenterol Hepatol. 2006 Jul;4(7):908-11.
  • [1]. Stolk MF, et al. Severe hepatic side effects of ezetimibe. Clin Gastroenterol Hepatol. 2006 Jul;4(7):908-11.
  • [2]. Lee DH, et al. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Free Radic Biol Med. 2016 Sep 12;99:520-532.

安全信息

GHS Symbol
Safety Statements
Precautionary statements

系列性分类


相关产品推荐